Purpose: Podocytes are important architectures that maintain the crucial roles of glomerular filtration barrier functions. Despite this structural importance, however, the mechanisms of the changes in podocytes that can be an important pathogenesis of minimal change nephrotic syndrome (MCNS) are not clear yet. The aim of this study was to investigate whether apoptosis is induced by interleukin (IL)-13 in cultured human podocytes. Methods: Human podocytes were treated with different IL-13 doses and apoptotic cells were analyzed using terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL assay) and fluorescence-activated cell sorting (FACS). Results: The IL-13 increased the number of TUNEL-positive cells in a dose-dependent manner at 6 and 18 hours (P<0.05 and P<0.05, respectively). The apop tosis rate was appeared to be increased slightly in the IL-13-stimulated podocytes (8.63 %, 13.02%, and 14.46%; 3, 10 and 30 ng/mL, respectively) than in the control cells (7.66%) at 12 hours by FACS assay. Conclusion: Our study revealed that IL-13 expression may increase podocyte apoptosis. Blocking the IL-13 signal pathway can potentially play an important role in regulating the apoptosis of podocytes.
Introduction
Minimal change nephrotic syndrome (MCNS) accounts for 84.5% of idio pathic nephrotic syndrome (INS) in children, and 10 to 25% of INS in adults 1, 2) . About 80-90% of children with childhood INS are steroidsensitive ne phrotic syndrome (SSRS) and around 60% of MCNS children show SSRS 3, 4) . Even though initial response rate to steroids is 90% to 95%, 20-60% of SSRS children relapse and about 60-90% of them will have five or more relapses with increased morbidity 4, 5) . Resistance to therapy, also called as steroidre sistant nephrotic syndrome (SRNS), occurs in 50% of focal segmental glo merulosclerosis (FSGS) and 10% of MCNS often progress to renal failure re quiring dialysis and transplantation despite various immunosuppressive treatments 69) . MCNS is composed of two important pathologic features: 1) absence of glomerular immune complex deposition and 2) foot process effacement (podo cytes seem to be fused together a flattened morphology) 8) . Foot process effacement is closely related the changes in the selective barrier in the slit diaphragm, which is composed of a number of proteins: nephrin, Pcadherin, CD2asso ciated protein, zona occludens (ZO)1, Fat cad herin, podo cin, and Neph1 10, 11) . Interleukin (IL)13 is a kind of T cellderived cytokine 12) . It is also reported to be an important cytokine in MCNS and we previously reported that IL13 may increase podo cyte permeability through the modulation of ZO1 13, 14) .
How ever, there have been no reports about podocyte apop tosis related to IL13. The aim of this study was to investi gate whether apoptosis is induced by IL13 in cultured human podocytes.
Materials and methods

Cell culture of human podocytes
Human conditionally immortalized podocytes (AB8/23) was cloned from human glomerular cultures. Dr. Moin A. Saleem (University of Bristol, Bristol, UK) cha racterized and generously provided them. Then human podocytes were maintained in RPMI 1640 (WelGENE Inc., Daegu, South Korea) supplemented with 10% heatinacti vated fetal bovine serum (FBS), InsulinTransferrinSele nium Pyruvate Supplement (ITSP; WelGENE Inc.), and anti biotics. Once every 2 days, fresh media was supplied.
Cells were cultivated at 33℃ (permissive conditions) in a culture medium supplemented with human recombinant ITSP to induce expression of temperaturesensitive large T antigens and to stimulate human podocyte proliferation. To induce differentiation, podocytes were maintained at 37℃ (nonpermissive conditions) for at least 2 weeks, and for subcultures, 0.05% trypsin was used to detach cells from the culture dishes.
IL-13 treatment conditions
To imitate MCNSlike conditions, cells were incubated with various concentrations of IL13 (Peprotech Inc., Rocky Hill, NJ, USA) during the indicated time periods (6, 12 and 18 hours). IL13 was administered with various concentra tions (3, 10, 30 , and 100 ng/mL) into 0.5% RPMI at 37℃.
Measurement of apoptosis
1) Terminal deoxynucleotidyl transferase dUTP nickend
labeling (TUNEL assay) TUNEL assay was done using In situ Cell Death Detec tion Kit (Roche Molecular Biochemicals, Mannheim, Germany). Podocytes that were grown on type I collagen coated glass coverslips incubated for 24 hours were fixed in 4% paraformaldehyde for 1 hour, followed by permea bilization with 0.1% Triton X100 for 10 minutes at room temperature. After coverslips were mounted in mountant, the samples were immediately evaluated using a fluores cence microscope. The TUNEL index (apoptotic podocytes) was determined by counting the positively and negatively stained cells in each of 10 fields of vision. Cell numbers were converted to percent apoptotic cells for statistical analysis.
2) Fluorescenceactivated cell sorting (FACS)
We conducted a flow cytometric analysis to elucidate whether IL13 has apoptotic effects on podocytes. The ap optotic rate was calculated by a singlecolor flow cytometric analysis depending upon the IL13 concentrations (control, 3, 10, and 30 ng/mL) and apoptotic hours (6 and 12 hours). Equal numbers of podocytes were cultivated on 6 cm tissue culture plates in medium. After IL13 modulation, cell cul ture medium was collected and saved. Cells were washed once with 1.5 ml of phosphatebuffered saline (PBS). PBS used for washing was combined with the saved culture medium. Podocyte cells were analyzed with the Mofro Astrios flow cytometer (FACSCaliburS System, Becton Dickinson Biosciences, San Jose, CA, USA). The number of apoptotic cells was calculated by multiplying the percen tages of apoptosis and necrosis as determined by FACS.
Statistical analysis
Results are described as mean ± standard deviation, as appropriate under different conditions. Statistical signifi cance was evaluated by the nonparametric KruskalWallis analysis or Student's ttest. Pvalues <0.05 were considered significant.
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Results
Apoptotic rate on TUNEL assay
Apoptosis is a programmed cell death which results the series of events including alterations in the plasma mem brane, activation of enzymes 15) . DNA fragmentation can be detected in terminal stages of apoptosis by labeling with fluorescent tagged nucleotides through a technique called as TUNEL 16) . Apoptotic podocytes were identified as TUNEL positive cells while the normal cells lacked nuclear staining. IL13 increased the number of TUNELpositive cells in a dosedependent manner at 6 and 18 hours (P<0.05 and P<0.05, respectively) ( Fig. 1, 2 ).
FACS assay for apoptosis
The apoptotic effects of IL13 on podocytes were an alyzed by FACS. There was no significant difference in the rate of apoptosis in controls and podocytes stimulated by different concentrations (3, 10 and 30 ng/mL) at 6 hours (9.73% vs. 13.89%, 12.52%, 10.83%, respectively, Fig. 3) ; at 12 hours, however, the rate of apoptosis was slightly in creased in IL13 stimulated podocytes (8.63%, 13.02%, 14.46%) than control cells (7.66%, Fig. 4 ).
Discussion
Podocytes are important structures which maintain the crucial roles of glomerular filtration barrier functions 9, 10) . In 2007, Lai et al. suggested that IL13 overexpression could lead to podocyte injury with downregulation of proteins such as nephrin, podocin, and dystroglycan and a concur rent upregulation of B71 in MCNS induced rat 17) . After that, our previous studies reported that IL13 was involved in the changes of ZO1 proteins in podocytes which could www.chikd.org be a pathogenesis of MCNS 14, 18) . Other recent studies have shown that increase in IL13 production was to cause fre quent relapse in SSNS 13, 19) . In this point of view, the aim of this study was to identify whether apoptosis in podocytes could be induced by IL13.
There have been two suspected modes of podocyte apop tosis: 1) intrinsic apoptosis and 2) extrinsic apoptosis. In trinsic apoptosis is related to a mitochondrioncentered control mechanism 20) . On the other hand, extrinsic apop tosis is a caspasedependent cell death related to activation of the caspase9caspase3 cascade 21, 22) . Generally, caspase 3 is known as a key mediator as a leading enzyme in cell death 23) . Procaspase3 is usually processed by autoproteo lytic cleavage and activated caspase3 has been identified that are related to mitochondrial cytochrome c release and caspase9 function 24, 25) . Manna et al. reported that IL13 is a potent inhibitor of TNFmediated activation and caspase 3 related apoptosis in 1998 26) . In contrast, recent studies show IL13 induces apoptotic pathways of cell death in head and neck cancer models 27, 28) . IL13 has been known as a causative factor of cell apop tosis in several previous studies. Borowski et al. reported that IL13 can be a mediator on lung epithelial cells as an apoptotic effector, which leads to loss of functional airway tissue and finally results in asthma 29) . Several studies have already reported about the role of IL13 as a pathogen in other cells and diseases other than podocytes. Heller et al. found that IL13 can effect on in testinal epithelial barrier dysfunction and eventually cause ulcerative colitis 30) . For this explanation, signal transduc tion qualities mediated by the respective receptors for IL-13 may result in distinct patterns of transcription regula tion, ultimately explaining the unique role of IL-13 in asthma pathogenesis. JAK/STAT activation pathway can be an optional mechanism to explain these results 31) . This pathway is induced by the IL-13 receptor complex and then eventually causes cell apoptosis and destruction of cell junc tions 31) . Exact mechanisms of these mediators, however, are unclear.
In this study, it is implicated that IL13 can induce po docyte apoptosis. Our results and previous studies above indicate that IL13 can be related to extrinsic apop tosis of podocyte, blocking this signal pathway.
Our study has several limitations: First, we were unable to reveal all exact mechanism of IL13 in podocytes. Second, we did not include treatment attempt to prevent podocyte apoptosis into our experiments. Despite these limitations, our study is the first attempt to demonstrate the IL13 as a key marker and potential treatment target to prevent changes related to cell death in human podocytes.
In conclusion, our preliminary results suggest that IL13 may increase podocyte apoptosis. Such alterations can be relevant to the foot process changes in podocytes related to pathogenesis of proteinuria in the IL13induced MCNS model. Further studies about the methods of suppression of IL13 are needed, and it will be noteworthy to explore whether IL13 modulation can modify podocytes from MCNS. 
